Cargando…

Newly Substituted Anilino-Fluoroquinolones with Proliferation Inhibition Potential against a Panel of Cancer Cell Lines

BACKGROUND: From a chemistry point of view, we hypothesized that superlative dual cytotoxicity-radical scavenging bioefficacies of series 4 FQs correlate to their acidic groups and C8-C7 ethylene diamine Chelation Bridge. METHODOLOGY: Newly synthesized 16 lipophilic-acid chelating FQs have been scre...

Descripción completa

Detalles Bibliográficos
Autores principales: Salih, Mohammed Ameen Fouad, Al-Hiari, Yusuf, Kasabri, Violet, Darwish, Rula, Abumansour, Hamza, Bourghli, Laurance, Al Alawi, Sundus, Albashiti, Rabab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727339/
https://www.ncbi.nlm.nih.gov/pubmed/35901360
http://dx.doi.org/10.31557/APJCP.2022.23.7.2507
_version_ 1784844993964277760
author Salih, Mohammed Ameen Fouad
Al-Hiari, Yusuf
Kasabri, Violet
Darwish, Rula
Abumansour, Hamza
Bourghli, Laurance
Al Alawi, Sundus
Albashiti, Rabab
author_facet Salih, Mohammed Ameen Fouad
Al-Hiari, Yusuf
Kasabri, Violet
Darwish, Rula
Abumansour, Hamza
Bourghli, Laurance
Al Alawi, Sundus
Albashiti, Rabab
author_sort Salih, Mohammed Ameen Fouad
collection PubMed
description BACKGROUND: From a chemistry point of view, we hypothesized that superlative dual cytotoxicity-radical scavenging bioefficacies of series 4 FQs correlate to their acidic groups and C8-C7 ethylene diamine Chelation Bridge. METHODOLOGY: Newly synthesized 16 lipophilic-acid chelating FQs have been screened for in vitro duality of proliferation inhibition and radical scavenging capacities. RESULTS: Substantially in LPS prompted RAW264.7 macrophages inflammation, IC50 values (µM) in the ascending order of new FQs’ NO scavenging/antiinflammation capacity were 4e<4b<3d<4f<5c<indomethacin (17.6<25.5<27.7<38.5<46.1< indomethacin’s 55.1, respectively). Exceptionally reduced FQ 4b exhibited comparable DPPH radical scavenging capacity to ascorbic acid (IC50 values (µM) 4.3 vs. 3.4, p>0.05). In comparison to classical and robust antineoplastic agent cisplatin and unlike triazoloFQs; nitroFQs (3a, 3b and 3f) and the reduced FQs (4a, 4c, 4d and 4e) exerted antiproliferation IC50 values <50 µM in leukaemia K562. Besides nitroFQ 3, the reduced FQs (4c and 4f) exhibited antineoplastic IC50 values <50 µM in lung A549 carcinoma. NitroFQ 3c and reduced FQs 4b, 4c, and 4f in breast MCF7 and reduced 4c in pancreatic PANC1 had reduction of viability IC50 values <50 µM. NitroFQ 3e, reduced FQs 4b and, 4c and triazoloFQ 5a exerted antiproliferation IC50 values <50 µM in breast T47D cells. Also nitroFQ 3e, reduced FQ 4c and triazoloFQ 5f exhibited antineoplastic IC50 values <50 µM in PC3 prostate cancer cells. Exceptionally triazoloFQ 5a, but neither nitro- nor reduced FQs, had cytotoxicity IC50 value <50 µM in resistant melanoma A375 cells. Unequivocally 4b antineoplastic effectiveness linked with its radical scavenging and antiinflammation effects while 3d and 5c lacked matching antiproliferation potentialities to their exquisite antiinflammation capacities. Explicitly reduced 4e and 4f exerted antiinflammation-selective cytotoxicity duality in vitro. CONCLUSION: Collectively, this work reveals lipophilic-acidic chelator FQs as authentic agents for the repurposing approach in anticancer chemotherapy/prevention.
format Online
Article
Text
id pubmed-9727339
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-97273392022-12-09 Newly Substituted Anilino-Fluoroquinolones with Proliferation Inhibition Potential against a Panel of Cancer Cell Lines Salih, Mohammed Ameen Fouad Al-Hiari, Yusuf Kasabri, Violet Darwish, Rula Abumansour, Hamza Bourghli, Laurance Al Alawi, Sundus Albashiti, Rabab Asian Pac J Cancer Prev Research Article BACKGROUND: From a chemistry point of view, we hypothesized that superlative dual cytotoxicity-radical scavenging bioefficacies of series 4 FQs correlate to their acidic groups and C8-C7 ethylene diamine Chelation Bridge. METHODOLOGY: Newly synthesized 16 lipophilic-acid chelating FQs have been screened for in vitro duality of proliferation inhibition and radical scavenging capacities. RESULTS: Substantially in LPS prompted RAW264.7 macrophages inflammation, IC50 values (µM) in the ascending order of new FQs’ NO scavenging/antiinflammation capacity were 4e<4b<3d<4f<5c<indomethacin (17.6<25.5<27.7<38.5<46.1< indomethacin’s 55.1, respectively). Exceptionally reduced FQ 4b exhibited comparable DPPH radical scavenging capacity to ascorbic acid (IC50 values (µM) 4.3 vs. 3.4, p>0.05). In comparison to classical and robust antineoplastic agent cisplatin and unlike triazoloFQs; nitroFQs (3a, 3b and 3f) and the reduced FQs (4a, 4c, 4d and 4e) exerted antiproliferation IC50 values <50 µM in leukaemia K562. Besides nitroFQ 3, the reduced FQs (4c and 4f) exhibited antineoplastic IC50 values <50 µM in lung A549 carcinoma. NitroFQ 3c and reduced FQs 4b, 4c, and 4f in breast MCF7 and reduced 4c in pancreatic PANC1 had reduction of viability IC50 values <50 µM. NitroFQ 3e, reduced FQs 4b and, 4c and triazoloFQ 5a exerted antiproliferation IC50 values <50 µM in breast T47D cells. Also nitroFQ 3e, reduced FQ 4c and triazoloFQ 5f exhibited antineoplastic IC50 values <50 µM in PC3 prostate cancer cells. Exceptionally triazoloFQ 5a, but neither nitro- nor reduced FQs, had cytotoxicity IC50 value <50 µM in resistant melanoma A375 cells. Unequivocally 4b antineoplastic effectiveness linked with its radical scavenging and antiinflammation effects while 3d and 5c lacked matching antiproliferation potentialities to their exquisite antiinflammation capacities. Explicitly reduced 4e and 4f exerted antiinflammation-selective cytotoxicity duality in vitro. CONCLUSION: Collectively, this work reveals lipophilic-acidic chelator FQs as authentic agents for the repurposing approach in anticancer chemotherapy/prevention. West Asia Organization for Cancer Prevention 2022-07 /pmc/articles/PMC9727339/ /pubmed/35901360 http://dx.doi.org/10.31557/APJCP.2022.23.7.2507 Text en https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License. https://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Research Article
Salih, Mohammed Ameen Fouad
Al-Hiari, Yusuf
Kasabri, Violet
Darwish, Rula
Abumansour, Hamza
Bourghli, Laurance
Al Alawi, Sundus
Albashiti, Rabab
Newly Substituted Anilino-Fluoroquinolones with Proliferation Inhibition Potential against a Panel of Cancer Cell Lines
title Newly Substituted Anilino-Fluoroquinolones with Proliferation Inhibition Potential against a Panel of Cancer Cell Lines
title_full Newly Substituted Anilino-Fluoroquinolones with Proliferation Inhibition Potential against a Panel of Cancer Cell Lines
title_fullStr Newly Substituted Anilino-Fluoroquinolones with Proliferation Inhibition Potential against a Panel of Cancer Cell Lines
title_full_unstemmed Newly Substituted Anilino-Fluoroquinolones with Proliferation Inhibition Potential against a Panel of Cancer Cell Lines
title_short Newly Substituted Anilino-Fluoroquinolones with Proliferation Inhibition Potential against a Panel of Cancer Cell Lines
title_sort newly substituted anilino-fluoroquinolones with proliferation inhibition potential against a panel of cancer cell lines
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727339/
https://www.ncbi.nlm.nih.gov/pubmed/35901360
http://dx.doi.org/10.31557/APJCP.2022.23.7.2507
work_keys_str_mv AT salihmohammedameenfouad newlysubstitutedanilinofluoroquinoloneswithproliferationinhibitionpotentialagainstapanelofcancercelllines
AT alhiariyusuf newlysubstitutedanilinofluoroquinoloneswithproliferationinhibitionpotentialagainstapanelofcancercelllines
AT kasabriviolet newlysubstitutedanilinofluoroquinoloneswithproliferationinhibitionpotentialagainstapanelofcancercelllines
AT darwishrula newlysubstitutedanilinofluoroquinoloneswithproliferationinhibitionpotentialagainstapanelofcancercelllines
AT abumansourhamza newlysubstitutedanilinofluoroquinoloneswithproliferationinhibitionpotentialagainstapanelofcancercelllines
AT bourghlilaurance newlysubstitutedanilinofluoroquinoloneswithproliferationinhibitionpotentialagainstapanelofcancercelllines
AT alalawisundus newlysubstitutedanilinofluoroquinoloneswithproliferationinhibitionpotentialagainstapanelofcancercelllines
AT albashitirabab newlysubstitutedanilinofluoroquinoloneswithproliferationinhibitionpotentialagainstapanelofcancercelllines